# US 2004/0001832 A1 · Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alstroem syndrome

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0001832 A1
- Document ID: US20040001832A1
- Status: Published application
- Kind: A1
- Application number: 10/292,576
- Filed: 2002-11-12
- Published: 2004-01-01
- Earliest claimed: 2001-11-09
- Inventors: Gayle B. Collin; Jan Marshall; Mitchell L. Martin; Juergen K. Naggert; Patsy M. Nishina; W. Venus So
- Web page: https://patentgrep.com/patent/US20040001832A1

## CPC

- G01N 33/6893: {related to diseases not provided for elsewhere}
- C07K 14/47: from mammals
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- G01N 2500/20: cell-free systems
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention relates to a nucleic acid sequence linked to Alström syndrome, variants of that nucleic acid sequence, the protein produced by that nucleic acid sequence and screening methods for testing individuals to determine if they are carriers of Alström syndrome.

## Claims

### Claim 1

An isolated nucleic acid molecule selected from the group consisting of:
nucleotide sequence SEQ ID NO:NO: 1,
nucleotide sequences hybridizing to SEQ ID NO:NO: 1 or the complement of SEQ ID NO:NO: 1 under stringent hybridization conditions and
nucleotide sequences encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:NO: 2.

### Claim 2 (depends on 1)

The nucleic acid molecule of claim 1, selected from the group consisting of:
a nucleotide sequence comprising SEQ ID NO:NO: 1 with 19 nucleotides inserted after the 3737th nucleotide of SEQ ID NO:NO: 1;
a nucleotide sequence comprising SEQ ID NO:NO: 1 with the 1582nd nucleotide of SEQ ID NO:NO: 1 being T;
a nucleotide sequence comprising SEQ ID NO:NO: 1 with the 3808th nucleotide of SEQ ID NO:NO: 1 being T, the 3809th nucleotide of SEQ ID NO:NO: 1 being deleted and the 3813th nucleotide of SEQ ID NO:NO: 1 being A;
a nucleotide sequence comprising SEQ ID NO:NO: 1 with the 3974th nucleotide of SEQ ID NO:NO: 1 being deleted;
a nucleotide sequence comprising SEQ ID NO:NO: 1 with the 4648th of SEQ ID NO: 1 being T; and
a nucleotide sequence comprising SEQ ID NO: 1 with an A inserted after the 1594th nucleotide of SEQ ID NO: 1.

### Claim 3 (depends on 1)

The nucleic acid molecule of claim 1, further comprising vector nucleic acid sequences.

### Claim 4 (depends on 1)

The nucleic acid molecule which is at least about 70% identical to the entire length of the nucleic acid molecule of claim 1.

### Claim 5 (depends on 1)

The nucleic acid molecule which is at least about 80% identical to the entire length of the nucleic acid molecule of claim 1.

### Claim 6 (depends on 1)

The nucleic acid molecule which is at least about 90% identical to the entire length of the nucleic acid molecule of claim 1.

### Claim 7 (depends on 1)

The nucleic acid molecule which is at least about 95% identical to the entire length of the nucleic acid molecule of claim 1.

### Claim 8

An isolated host cell comprising a nucleic acid molecule selected from the group consisting of
nucleotide sequence SEQ ID NO: 1,
nucleotide sequences hybridizing to SEQ ID NO: 1 or the complement of SEQ ID NO: 1 under stringent hybridization conditions and
nucleotide sequences encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 2.

### Claim 9 (depends on 8)

The host cell of claim 8 which is a mammalian host cell.

### Claim 10 (depends on 8)

A method for producing a polypeptide comprising culturing the host cell of claim 8 under conditions in which the nucleic acid molecule is expressed.

### Claim 11

An isolated polypeptide comprising an amino acid sequence selected from the group consisting of
the amino acid sequence of SEQ ID NO: 2,
the amino acid sequence encoded by the nucleic acid molecule having the nucleotide sequence SEQ ID NO: 1,
the amino acid sequence encoded by the nucleic acid molecule having nucleotide sequences hybridizing to SEQ ID NO: 1 or the complement of SEQ ID NO: 1 under stringent hybridization conditions and
the amino acid sequence encoded by the nucleic acid molecule having nucleotide sequences encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 2.

### Claim 12

An isolated polypeptide comprising at least 50 contiguous amino acid residues of the amino acid sequence of SEQ ID NO: 2.

### Claim 13

An isolated polypeptide comprising at least 100 contiguous amino acid residues of the amino acid sequence of SEQ ID NO: 2.

### Claim 14

An isolated polypeptide comprising at least 200 contiguous amino acid residues of the amino acid sequence of SEQ ID NO: 2.

### Claim 15

A method of diagnosing Alström Syndrome or screening for carriers of Alström Syndrome comprising testing genetic material from a putative carrier for mutations in SEQ ID NO: 1 of ALMS1.

### Claim 16

A method of diagnosing Alström Syndrome in a patient, the method comprising determining the presence or absence of the protein encoded by SEQ ID NO: 1 in a tissue sample of the patient.

### Claim 17 (depends on 16)

The method of claim 16, wherein the step of determining the presence or absence of the protein encoded by SEQ ID NO: 1 is performed by adding an antibody specific for the protein encoded by SEQ ID NO: 1 to proteins from the tissue sample and determining the amount of antibody which binds to the proteins from the tissue sample.

### Claim 18

A method for identifying a compound suitable for treating Alström Syndrome comprising:
contacting a polypeptide having the amino acid sequence of SEQ ID NO: 2 or a fragment thereof, or a cell expressing a polypeptide having the amino acid sequence of SED ID NO: 2 or a fragment thereof, with a test compound; and
determining whether said polypeptide or fragment thereof binds to said test compound, thereby identifying a compound suitable for treating Alström Syndrome.
